Stock screener

AQST

Conviction 55HealthcareScan · Thu, Sep 24, 2026
Bullish harami

Aquestive Therapeutics, Inc. (AQST) closed at $4.83 (+2.77%) on Sep 24, 2026. Its latest daily candle is a bullish harami. Price is above its 50-day and above its 200-day moving average. RSI(14) 51, RS Rating 53, -35.5% from its 52-week high, -25.1% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

AQST$4.83+2.77%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 2.44M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Aquestive Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.aquestive.com ↗
Price4.83
Change+2.77%
Gap+0.74%
Rel volume0.95×
Avg volume2.4M
Avg $ vol11.93M
SMA 204.99
SMA 504.48
SMA 2004.39
Price vs 50+7.86%
Price vs 200+10.07%
MA stackbullish
50/200 crossgolden · 3d
Supertrenddown · 5.33
RSI (14)51
MACD hist-0.06
MACD cross—
Stoch %K / %D33 / 32
ADX (14)25
+DI / −DI24 / 20
RSI divergence—
MACD divergence—
ATR %5.34%
ADR %5.01%
52w high7.49
52w low2.95
From 52w high-35.51%
Above 52w low+63.73%
New 52w highNo
SqueezeOff
Bollinger width18.90%
%B0.33
Donchian pos32.82%
Donchian high5.49
Donchian low4.51
AVWAP (52w high)4.55
vs AVWAP high+6.13%
AVWAP (52w low)4.25
vs AVWAP low+13.59%
OBV trendDown
Chaikin MF (20)-0.10
Today vs 20d0.95×
Avg vol (14d)2.44M
Avg vol (20d)2.4M
Avg $ vol (20d)11.93M
Market cap606.22M
RS Rating53 / 99
RS 3m (vs SPY)+3.68%
RS 6m (vs SPY)-2.09%
RS line new highNo
Trend template4/8
Technical rank72.0
1 week+3.65%
1 month-4.92%
3 months+8.17%
6 months+14.73%
1 year-7.12%
YTD-25.12%
P/E-7.24
P/B-10.71
P/S13.61
P/FCF-11.44
EPS-0.7800
Div yield—
ROE148.06%
ROA-63.42%
Debt/Eq-0.97
Current7.19
EV/EBITDA-8.29
Gross margin—
Net margin-188.09%
Rev growth-22.61%
EPS growth-89.83%
Price target9.00
Target upside86.34%
Analyst ratingBuy
Institutional62.29%
Ent. value562.76M
Revenue13.82M
Net income-22.86M
Gross profit—
Free cash flow-52.99M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out125.45M
Employees147
ListedWed, Jul 25, 2018
Free float99.96M
Float %81.9%
Short interest25.48M
Days to cover7.2d
Short volume48.7%
Squeeze score71 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.18 vs −$0.10
Last surprise-80.0% miss
Setup gradeC
Conviction55 / 100
Pattern quality—
Tech rank72.0 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish harami

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AQST

All disclosures →
No recent disclosed trades by Congress in AQST. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AQST · open-market 3 sells

InsiderSideShares
Korczynski Sherry
Chief Commercial Officer · Common Stock · 2026-09-09
Sell8.75K
Korczynski Sherry
Chief Commercial Officer · Common Stock · 2026-09-09
Exercise8.75K
Korczynski Sherry
Chief Commercial Officer · Non-Qualified Stock Option (right to buy) · 2026-09-09
Exercise8.75K
Barber Daniel
President and CEO · Common Stock · 2026-09-08
Exercise91.74K
Barber Daniel
President and CEO · Warrant (Right to Buy) · 2026-09-08
Exercise91.74K
Jung Cassie
Chief Operating Officer · Common Stock · 2026-09-03
Exercise4.59K
Jung Cassie
Chief Operating Officer · Warrant (Right to Buy) · 2026-09-03
Exercise4.59K
Barber Daniel
President and CEO · Common Stock · 2026-08-17
Sell25K
Korczynski Sherry
Chief Commercial Officer · Common Stock · 2026-08-14
Tax2.71K
Barber Daniel
President and CEO · Common Stock · 2026-07-16
Sell20.37K

SEC filings

EDGAR filings in AQST · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.